Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA Processing, Post-Transcriptional | 16 | 2023 | 415 | 4.910 |
Why?
|
RNA, Transfer | 7 | 2024 | 291 | 4.040 |
Why?
|
MicroRNAs | 45 | 2021 | 3796 | 4.010 |
Why?
|
Methyltransferases | 10 | 2024 | 377 | 3.860 |
Why?
|
RNA-Binding Proteins | 34 | 2021 | 1897 | 3.700 |
Why?
|
Exoribonucleases | 6 | 2020 | 95 | 2.520 |
Why?
|
Embryonic Stem Cells | 13 | 2020 | 1262 | 2.200 |
Why?
|
RNA, Messenger | 17 | 2024 | 12785 | 2.050 |
Why?
|
Ribonuclease III | 12 | 2021 | 278 | 1.860 |
Why?
|
Protein Biosynthesis | 6 | 2024 | 2114 | 1.700 |
Why?
|
Codon | 3 | 2024 | 602 | 1.610 |
Why?
|
Guanosine | 3 | 2021 | 48 | 1.490 |
Why?
|
Uridine | 5 | 2019 | 142 | 1.480 |
Why?
|
Fetal Macrosomia | 3 | 2020 | 140 | 1.210 |
Why?
|
RNA Nucleotidyltransferases | 4 | 2016 | 62 | 1.200 |
Why?
|
GTP-Binding Proteins | 2 | 2023 | 950 | 1.070 |
Why?
|
Wilms Tumor | 3 | 2020 | 379 | 1.050 |
Why?
|
Sequence Analysis, RNA | 4 | 2021 | 2018 | 1.010 |
Why?
|
Cytidine | 2 | 2024 | 65 | 0.970 |
Why?
|
Ribosomes | 4 | 2021 | 501 | 0.940 |
Why?
|
RNA Stability | 5 | 2022 | 331 | 0.830 |
Why?
|
RNA Interference | 12 | 2016 | 2832 | 0.830 |
Why?
|
DNA-Binding Proteins | 10 | 2019 | 9598 | 0.800 |
Why?
|
Open Reading Frames | 2 | 2023 | 815 | 0.800 |
Why?
|
tRNA Methyltransferases | 1 | 2021 | 52 | 0.760 |
Why?
|
RNA-Induced Silencing Complex | 3 | 2013 | 56 | 0.760 |
Why?
|
Adenosine | 4 | 2024 | 804 | 0.750 |
Why?
|
Eukaryotic Initiation Factor-3 | 2 | 2018 | 50 | 0.750 |
Why?
|
Germ Layers | 1 | 2021 | 72 | 0.740 |
Why?
|
Signal Recognition Particle | 2 | 2020 | 47 | 0.730 |
Why?
|
RNA, Small Cytoplasmic | 2 | 2020 | 19 | 0.730 |
Why?
|
Informatics | 1 | 2021 | 72 | 0.710 |
Why?
|
Serine | 1 | 2024 | 828 | 0.710 |
Why?
|
Molecular Sequence Annotation | 2 | 2020 | 522 | 0.700 |
Why?
|
RNA, Ribosomal, 5.8S | 1 | 2019 | 2 | 0.680 |
Why?
|
Cell Cycle | 4 | 2024 | 2929 | 0.680 |
Why?
|
Gene Expression Regulation, Developmental | 5 | 2021 | 3609 | 0.670 |
Why?
|
RNA Splicing | 3 | 2022 | 915 | 0.660 |
Why?
|
RNA, Small Nuclear | 1 | 2018 | 75 | 0.620 |
Why?
|
Gene Silencing | 9 | 2021 | 1509 | 0.620 |
Why?
|
Software | 3 | 2020 | 4426 | 0.570 |
Why?
|
Mice | 42 | 2024 | 81402 | 0.560 |
Why?
|
Gene Dosage | 1 | 2021 | 1218 | 0.550 |
Why?
|
Cell Nucleus | 3 | 2022 | 2906 | 0.530 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2016 | 100 | 0.510 |
Why?
|
Methylation | 5 | 2024 | 1082 | 0.510 |
Why?
|
Hep G2 Cells | 4 | 2021 | 379 | 0.500 |
Why?
|
Genomic Imprinting | 6 | 2015 | 330 | 0.500 |
Why?
|
Animals | 55 | 2024 | 168253 | 0.500 |
Why?
|
RNA | 3 | 2021 | 2721 | 0.490 |
Why?
|
Ribonucleoproteins | 4 | 2013 | 372 | 0.480 |
Why?
|
Proteins | 8 | 2013 | 6033 | 0.470 |
Why?
|
DNA Damage | 1 | 2024 | 2441 | 0.470 |
Why?
|
Endoplasmic Reticulum | 1 | 2020 | 1133 | 0.460 |
Why?
|
Exonucleases | 1 | 2013 | 44 | 0.430 |
Why?
|
Drug Discovery | 1 | 2021 | 1054 | 0.430 |
Why?
|
Cell Line | 16 | 2019 | 15598 | 0.430 |
Why?
|
Small Molecule Libraries | 2 | 2017 | 732 | 0.430 |
Why?
|
RNA, Untranslated | 2 | 2016 | 459 | 0.430 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2013 | 194 | 0.410 |
Why?
|
Ribonucleases | 1 | 2013 | 276 | 0.410 |
Why?
|
Nuclear Proteins | 9 | 2016 | 5794 | 0.400 |
Why?
|
Gene Expression Regulation | 12 | 2020 | 11900 | 0.390 |
Why?
|
HEK293 Cells | 7 | 2024 | 4277 | 0.390 |
Why?
|
Pluripotent Stem Cells | 4 | 2016 | 800 | 0.380 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 359 | 0.380 |
Why?
|
Computational Biology | 3 | 2023 | 3510 | 0.370 |
Why?
|
Neoplasms | 6 | 2021 | 22083 | 0.360 |
Why?
|
Chromatin | 6 | 2004 | 2951 | 0.360 |
Why?
|
Cell Differentiation | 11 | 2024 | 11526 | 0.350 |
Why?
|
Nucleic Acid Conformation | 5 | 2018 | 899 | 0.340 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 319 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2021 | 8519 | 0.340 |
Why?
|
Transfection | 6 | 2018 | 5776 | 0.330 |
Why?
|
RNA, Small Interfering | 8 | 2019 | 3428 | 0.330 |
Why?
|
Enzyme Inhibitors | 2 | 2015 | 3710 | 0.320 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3610 | 0.320 |
Why?
|
Protein Binding | 9 | 2020 | 9340 | 0.300 |
Why?
|
HeLa Cells | 7 | 2018 | 3097 | 0.300 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 16945 | 0.290 |
Why?
|
Base Sequence | 8 | 2018 | 12449 | 0.290 |
Why?
|
RNA Precursors | 4 | 2015 | 212 | 0.280 |
Why?
|
Humans | 69 | 2024 | 760437 | 0.280 |
Why?
|
Calcium | 1 | 2020 | 5726 | 0.280 |
Why?
|
Uridine Monophosphate | 2 | 2020 | 68 | 0.280 |
Why?
|
Spliceosomes | 2 | 2018 | 130 | 0.270 |
Why?
|
Cell Lineage | 4 | 2021 | 2539 | 0.270 |
Why?
|
Transcription Factors | 4 | 2016 | 12121 | 0.270 |
Why?
|
5' Untranslated Regions | 2 | 2023 | 256 | 0.260 |
Why?
|
Molecular Sequence Data | 7 | 2015 | 17639 | 0.250 |
Why?
|
Mesoderm | 1 | 2008 | 673 | 0.240 |
Why?
|
Anticodon | 1 | 2024 | 26 | 0.240 |
Why?
|
Substrate Specificity | 2 | 2023 | 1792 | 0.240 |
Why?
|
Nerve Tissue Proteins | 3 | 2002 | 4413 | 0.230 |
Why?
|
Binding Sites | 4 | 2021 | 6042 | 0.220 |
Why?
|
Deoxyribonucleases | 2 | 2002 | 211 | 0.210 |
Why?
|
Fibroblasts | 3 | 2011 | 4106 | 0.210 |
Why?
|
Cells, Cultured | 7 | 2018 | 18955 | 0.210 |
Why?
|
Lung Neoplasms | 2 | 2018 | 13312 | 0.210 |
Why?
|
Biocatalysis | 1 | 2023 | 170 | 0.200 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1347 | 0.200 |
Why?
|
Eukaryota | 1 | 2023 | 102 | 0.200 |
Why?
|
Eukaryotic Initiation Factor-2 | 4 | 2013 | 181 | 0.190 |
Why?
|
RNA Editing | 2 | 2021 | 151 | 0.190 |
Why?
|
Protein Structure, Tertiary | 4 | 2015 | 3792 | 0.190 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2001 | 75 | 0.190 |
Why?
|
S-Adenosylhomocysteine | 1 | 2021 | 41 | 0.190 |
Why?
|
Hematopoietic Stem Cells | 4 | 2021 | 3396 | 0.190 |
Why?
|
Cell Proliferation | 9 | 2021 | 10425 | 0.180 |
Why?
|
CDC2 Protein Kinase | 1 | 2021 | 213 | 0.180 |
Why?
|
Catalytic Domain | 1 | 2023 | 705 | 0.180 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 2529 | 0.170 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2020 | 136 | 0.170 |
Why?
|
RNA Transport | 1 | 2019 | 45 | 0.170 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2011 | 1857 | 0.170 |
Why?
|
K562 Cells | 1 | 2021 | 642 | 0.170 |
Why?
|
Hydrazines | 1 | 2021 | 224 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 251 | 0.160 |
Why?
|
3' Flanking Region | 1 | 2018 | 15 | 0.160 |
Why?
|
Protein Conformation | 3 | 2021 | 3969 | 0.160 |
Why?
|
Cyclization | 1 | 2018 | 59 | 0.160 |
Why?
|
Polyribosomes | 1 | 2018 | 109 | 0.160 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2021 | 716 | 0.160 |
Why?
|
3T3 Cells | 1 | 2020 | 1084 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6330 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4567 | 0.150 |
Why?
|
Signal Transduction | 5 | 2016 | 23397 | 0.150 |
Why?
|
Histones | 4 | 2004 | 2577 | 0.150 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 749 | 0.150 |
Why?
|
Asparaginase | 1 | 2019 | 240 | 0.150 |
Why?
|
Pancreas | 1 | 2024 | 1684 | 0.150 |
Why?
|
Systems Integration | 1 | 2019 | 426 | 0.140 |
Why?
|
Immunoprecipitation | 2 | 2016 | 877 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3590 | 0.140 |
Why?
|
Autoantigens | 1 | 2001 | 876 | 0.140 |
Why?
|
RNA, Double-Stranded | 2 | 2011 | 295 | 0.140 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2002 | 774 | 0.140 |
Why?
|
Exons | 1 | 2022 | 2392 | 0.140 |
Why?
|
Biological Assay | 1 | 1999 | 626 | 0.140 |
Why?
|
Polymorphism, Single-Stranded Conformational | 3 | 2002 | 330 | 0.140 |
Why?
|
Nucleotidyltransferases | 1 | 2018 | 243 | 0.140 |
Why?
|
Mass Spectrometry | 2 | 2021 | 2189 | 0.130 |
Why?
|
Blotting, Southern | 3 | 2002 | 780 | 0.130 |
Why?
|
Deoxyribonuclease I | 3 | 2002 | 224 | 0.130 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1674 | 0.130 |
Why?
|
Catalysis | 2 | 2009 | 774 | 0.130 |
Why?
|
Neoplasm Invasiveness | 2 | 2016 | 3587 | 0.130 |
Why?
|
Peptide Initiation Factors | 2 | 2005 | 55 | 0.130 |
Why?
|
Calcium Signaling | 1 | 2020 | 733 | 0.130 |
Why?
|
Aniline Compounds | 1 | 2021 | 1069 | 0.130 |
Why?
|
Oncogenes | 1 | 2021 | 1223 | 0.130 |
Why?
|
Polymerase Chain Reaction | 4 | 2012 | 6086 | 0.120 |
Why?
|
Myocardium | 1 | 2008 | 4700 | 0.120 |
Why?
|
DNA Repair | 1 | 2024 | 2044 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2004 | 2821 | 0.120 |
Why?
|
Neoplasm Metastasis | 2 | 2021 | 4903 | 0.120 |
Why?
|
Up-Regulation | 3 | 2016 | 4116 | 0.120 |
Why?
|
DNA Methylation | 6 | 2015 | 4383 | 0.120 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9533 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2021 | 3610 | 0.120 |
Why?
|
Hematopoiesis | 3 | 2021 | 2049 | 0.110 |
Why?
|
Amino Acid Sequence | 4 | 2016 | 13445 | 0.110 |
Why?
|
Phosphorylation | 2 | 2023 | 8311 | 0.110 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 2013 | 49 | 0.110 |
Why?
|
Transcription, Genetic | 5 | 2016 | 7597 | 0.110 |
Why?
|
Sequence Alignment | 2 | 2015 | 2180 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2021 | 1250 | 0.110 |
Why?
|
Genes, Homeobox | 1 | 2014 | 285 | 0.110 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 1189 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 2 | 2014 | 383 | 0.110 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2104 | 0.110 |
Why?
|
Carboxypeptidases | 1 | 2013 | 154 | 0.110 |
Why?
|
Models, Biological | 4 | 2012 | 9462 | 0.100 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5778 | 0.100 |
Why?
|
Models, Molecular | 2 | 2021 | 5427 | 0.100 |
Why?
|
Endonucleases | 1 | 2015 | 369 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1899 | 0.100 |
Why?
|
Fetal Hemoglobin | 1 | 2015 | 345 | 0.100 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 1745 | 0.100 |
Why?
|
Mice, Nude | 1 | 2018 | 3603 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2016 | 2870 | 0.100 |
Why?
|
Cell Nucleolus | 1 | 2011 | 156 | 0.090 |
Why?
|
Puberty, Precocious | 1 | 2012 | 164 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1889 | 0.090 |
Why?
|
Leukemia | 1 | 2019 | 1522 | 0.090 |
Why?
|
Genes, Reporter | 2 | 2017 | 1528 | 0.090 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 425 | 0.090 |
Why?
|
Biological Transport | 1 | 2015 | 2090 | 0.090 |
Why?
|
Microcomputers | 1 | 2011 | 141 | 0.090 |
Why?
|
Glucose | 2 | 2013 | 4342 | 0.090 |
Why?
|
Cell Survival | 2 | 2021 | 5790 | 0.090 |
Why?
|
Molecular Structure | 1 | 2015 | 1875 | 0.090 |
Why?
|
Alleles | 4 | 2021 | 6908 | 0.090 |
Why?
|
Tacrolimus | 1 | 2013 | 733 | 0.090 |
Why?
|
Cell Count | 1 | 2014 | 1834 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2805 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1485 | 0.080 |
Why?
|
Models, Genetic | 3 | 2011 | 3445 | 0.080 |
Why?
|
Gene Expression | 4 | 2015 | 7582 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6525 | 0.080 |
Why?
|
Gene Knockdown Techniques | 3 | 2021 | 1610 | 0.080 |
Why?
|
Germ Cells | 1 | 2013 | 634 | 0.080 |
Why?
|
Immunoglobulin Class Switching | 1 | 2011 | 289 | 0.080 |
Why?
|
Cytidine Deaminase | 1 | 2011 | 245 | 0.080 |
Why?
|
Cell Line, Transformed | 2 | 2008 | 868 | 0.080 |
Why?
|
Stem Cells | 1 | 2002 | 3522 | 0.080 |
Why?
|
Acetylation | 2 | 2002 | 1054 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2012 | 718 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3818 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 988 | 0.080 |
Why?
|
Cell Movement | 2 | 2021 | 5198 | 0.080 |
Why?
|
Fertility | 1 | 2013 | 771 | 0.080 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 515 | 0.080 |
Why?
|
Carcinoma, Embryonal | 1 | 2008 | 37 | 0.080 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2749 | 0.080 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2011 | 649 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2021 | 2331 | 0.080 |
Why?
|
Lysosomes | 1 | 2013 | 919 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1063 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2297 | 0.070 |
Why?
|
Zebrafish | 2 | 2020 | 3002 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2008 | 140 | 0.070 |
Why?
|
Multienzyme Complexes | 1 | 2011 | 665 | 0.070 |
Why?
|
Zinc Fingers | 1 | 2009 | 572 | 0.070 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2007 | 85 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3631 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2008 | 1058 | 0.070 |
Why?
|
Kidney Tubules | 1 | 2008 | 449 | 0.070 |
Why?
|
Trans-Activators | 1 | 2016 | 2858 | 0.070 |
Why?
|
Carrier Proteins | 2 | 2016 | 4936 | 0.070 |
Why?
|
Kidney Glomerulus | 1 | 2008 | 567 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4923 | 0.070 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2008 | 431 | 0.070 |
Why?
|
Protein Stability | 2 | 2019 | 577 | 0.070 |
Why?
|
Diphosphates | 1 | 2005 | 84 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6591 | 0.060 |
Why?
|
Multiprotein Complexes | 3 | 2007 | 1119 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4319 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22121 | 0.060 |
Why?
|
Oocytes | 1 | 2009 | 1168 | 0.060 |
Why?
|
Lymphoproliferative Disorders | 1 | 2008 | 533 | 0.060 |
Why?
|
Podocytes | 1 | 2008 | 406 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2011 | 20985 | 0.060 |
Why?
|
Mutagenesis | 1 | 2008 | 1233 | 0.060 |
Why?
|
Chromatography, Gel | 1 | 2004 | 646 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5292 | 0.060 |
Why?
|
Genomics | 1 | 2019 | 5806 | 0.060 |
Why?
|
Chromatography, Affinity | 1 | 2004 | 532 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1824 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2571 | 0.050 |
Why?
|
Rats | 1 | 2019 | 23712 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9973 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3446 | 0.050 |
Why?
|
Molecular Weight | 1 | 2004 | 2188 | 0.050 |
Why?
|
Phosphates | 1 | 2005 | 770 | 0.050 |
Why?
|
snRNP Core Proteins | 1 | 2001 | 22 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2002 | 161 | 0.050 |
Why?
|
Mice, Knockout | 5 | 2019 | 14397 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 815 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10746 | 0.050 |
Why?
|
DNA Restriction Enzymes | 1 | 2001 | 555 | 0.050 |
Why?
|
Chromosomes, Human, X | 1 | 2002 | 321 | 0.050 |
Why?
|
Down-Regulation | 1 | 2008 | 2911 | 0.040 |
Why?
|
Kinetics | 1 | 2008 | 6377 | 0.040 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2007 | 872 | 0.040 |
Why?
|
Muridae | 1 | 1999 | 56 | 0.040 |
Why?
|
Blotting, Northern | 1 | 2002 | 1545 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2011 | 2687 | 0.040 |
Why?
|
Calmodulin | 1 | 2020 | 218 | 0.040 |
Why?
|
Mice, SCID | 2 | 2016 | 2625 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 1989 | 0.040 |
Why?
|
Hydroxamic Acids | 1 | 2002 | 481 | 0.040 |
Why?
|
Female | 9 | 2018 | 391875 | 0.040 |
Why?
|
Homeostasis | 1 | 2010 | 3320 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1999 | 786 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11070 | 0.040 |
Why?
|
Repressor Proteins | 3 | 2016 | 2978 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2020 | 452 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2002 | 2265 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13616 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 739 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2011 | 4748 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2017 | 102 | 0.040 |
Why?
|
Lysine | 1 | 2002 | 992 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2017 | 213 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2020 | 682 | 0.030 |
Why?
|
Lymphocytes | 2 | 2021 | 2610 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1956 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2020 | 1494 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 823 | 0.030 |
Why?
|
Protein Transport | 1 | 2021 | 1965 | 0.030 |
Why?
|
Gene Order | 1 | 2015 | 169 | 0.030 |
Why?
|
Point Mutation | 1 | 2020 | 1595 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 502 | 0.030 |
Why?
|
Immunoblotting | 1 | 2018 | 1647 | 0.030 |
Why?
|
Embryonic Development | 1 | 1999 | 717 | 0.030 |
Why?
|
gamma-Globins | 1 | 2015 | 99 | 0.030 |
Why?
|
Ubiquitination | 1 | 2019 | 1006 | 0.030 |
Why?
|
Brain | 1 | 2021 | 27060 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2016 | 658 | 0.030 |
Why?
|
Erythroid Cells | 1 | 2015 | 238 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1664 | 0.030 |
Why?
|
Growth and Development | 1 | 2013 | 47 | 0.030 |
Why?
|
Myoblasts, Skeletal | 1 | 2013 | 73 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2667 | 0.030 |
Why?
|
Castration | 1 | 2012 | 151 | 0.030 |
Why?
|
Retroviridae | 1 | 2015 | 850 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1314 | 0.030 |
Why?
|
Dwarfism | 1 | 2013 | 138 | 0.030 |
Why?
|
Male | 8 | 2019 | 360035 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2015 | 901 | 0.030 |
Why?
|
Mice, Inbred ICR | 1 | 2012 | 364 | 0.030 |
Why?
|
Spermatogenesis | 1 | 2013 | 258 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 934 | 0.020 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2012 | 171 | 0.020 |
Why?
|
Muscle Development | 1 | 2013 | 259 | 0.020 |
Why?
|
Phenotype | 3 | 2016 | 16585 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5663 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2911 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11095 | 0.020 |
Why?
|
Testis | 1 | 2013 | 794 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5031 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2058 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 2 | 2019 | 5662 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4391 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 1737 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12653 | 0.020 |
Why?
|
RNA, Helminth | 1 | 2007 | 60 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 1982 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10759 | 0.020 |
Why?
|
Endoribonucleases | 1 | 2008 | 228 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2013 | 1738 | 0.020 |
Why?
|
Time Factors | 2 | 2013 | 39947 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2012 | 1077 | 0.020 |
Why?
|
Kidney | 1 | 2002 | 7046 | 0.020 |
Why?
|
Fetus | 1 | 2013 | 1863 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2002 | 7849 | 0.020 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 304 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2015 | 3392 | 0.020 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2005 | 61 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2008 | 651 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9468 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13484 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6206 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2820 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 3028 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2008 | 685 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20078 | 0.010 |
Why?
|
R-SNARE Proteins | 1 | 2002 | 75 | 0.010 |
Why?
|
Hybrid Cells | 1 | 2002 | 422 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15867 | 0.010 |
Why?
|
Mutation | 1 | 2004 | 30025 | 0.010 |
Why?
|
Cohort Studies | 2 | 2012 | 41366 | 0.010 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2001 | 269 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10538 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 1549 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12976 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2001 | 794 | 0.010 |
Why?
|
CpG Islands | 1 | 2002 | 1225 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2007 | 1454 | 0.010 |
Why?
|
Pregnancy | 1 | 1999 | 29831 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2011 | 3956 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9410 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 1078 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18379 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 2001 | 706 | 0.010 |
Why?
|
Environment | 1 | 2001 | 1122 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26280 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36183 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42209 | 0.010 |
Why?
|
Obesity | 1 | 2011 | 12918 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 12127 | 0.000 |
Why?
|
Child | 1 | 2012 | 80086 | 0.000 |
Why?
|
Adolescent | 1 | 2012 | 88196 | 0.000 |
Why?
|
Adult | 1 | 2012 | 220781 | 0.000 |
Why?
|